Andrew Albert Kucharchuk

CIK: 0001654127

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

RREV

RRE Ventures Acquisition Corp.

Officer

CERO

CERO THERAPEUTICS HOLDINGS, INC.

Officer

RNGTU

Range Capital Acquisition Corp II

Officer

WINT

WINDTREE THERAPEUTICS INC /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CERO
CERO THERAPEUTICS HOLDINGS, INC.
Jan 7, 2026
Award(A)
Stock Option (Right to Buy)
Direct
1.2M shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
May 30, 2025
Award(A)
Stock Option (Right to Buy)
Direct
152.5K shares-
CERO
CERO THERAPEUTICS HOLDINGS, INC.
Oct 1, 2024
Award(A)
Stock Option (Right to Buy)
Direct
500K shares-

		Type	Shares	Price		Ownership
Jan 7, 2026	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	1,162,099	-	-	Direct
May 30, 2025	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	152,500	-	-	Direct
Oct 1, 2024	CERO CERO THERAPEUTICS HOLDINGS, INC.	Award(A) Stock Option (Right to Buy)	500,000	-	-	Direct

1-3 of 3 transactions

About KUCHARCHUK ANDREW ALBERT

KUCHARCHUK ANDREW ALBERT (SEC CIK 0001654127) files insider reports with the SEC as Chief Financial Officer of RRE Ventures Acquisition Corp. (RREV), Chief Financial Officer of CERO THERAPEUTICS HOLDINGS, INC. (CERO) and Chief Financial Officer of Range Capital Acquisition Corp II (RNGTU). Signal8 also holds filings tied to 1 other company.

Signal8 holds 7 ownership filings by KUCHARCHUK ANDREW ALBERT (4 Form 3, 3 Form 4), filed between Oct 2, 2024 and Apr 29, 2026. Those filings report 3 transactions, from Oct 1, 2024 to Jan 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on KUCHARCHUK ANDREW ALBERT's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by KUCHARCHUK ANDREW ALBERT

Jan 7, 2026: Grant or award of CERO derivative securities (Form 4, code A).
May 30, 2025: Grant or award of CERO derivative securities (Form 4, code A).
Oct 1, 2024: Grant or award of CERO derivative securities (Form 4, code A).

Other insiders filing for RRE Ventures Acquisition Corp. (RREV)

RRE Sponsor, LLC, 10% Owner
Epstein Jeffrey Douglas, President
Daly Brian Frederick, Director
Bernstein Bruce, Director
Mancini Robert Scott, Director
Kassin Philip (Phil), Chief Executive Officer

How to read Form 4 transaction codes